Justine O'Malley | Vice President, Corporate Affairs |
Mark Pruzanski | Chief Executive Officer |
Jerry Durso | Chief Operating Officer |
Sandip Kapadia | Chief Financial Officer |
Michael Yee | Jefferies |
Alethia Young | Cantor Fitzgerald |
Brian Abrahams | RBC Capital Markets |
Yasmeen Rahimi | Roth Capital Partners |
Brian Skorney | Baird |
Ritu Baral | Cowen and Company |
Salveen Richter | Goldman Sachs |
Steven Seedhouse | Raymond James |
Good morning ladies and gentlemen, and thank you for joining the Intercept Pharmaceuticals' Second Quarter 2019 Financial Results Conference Call. All participants are now in a listen-only mode.
Following opening remarks, Intercept's Management will open the lines for a question-and-answer period. Please be advised that this call is being recorded at the Company's request and a webcast of this call will be archived on the Company's website for approximately two weeks.
I would now like to introduce Justine O'Malley, Vice President, Corporate Affairs.